Angiotensin receptor blockers and myocardial infarction - Results reflect different cardiovascular states in patients with types 1 and 2 diabetes

被引：7

作者：

Lewis, EJ ^{[1
]}

机构：

[1] Rush Univ, Med Ctr, Nephrol Sect, Chicago, IL 60612 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7502期

关键词：

D O I：

10.1136/bmj.330.7502.1269-a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1269 / +

页数：3

共 7 条

[1] Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].

Berl, T ;

Hunsicker, LG ;

Lewis, JB ;

Pfeffer, MA ;

Porush, JG ;

Rouleau, JL ;

Drury, PL ;

Esmatjes, E ;

Hricik, D ;

Parikh, CR ;

Raz, I ;

Vanhille, P ;

Wiegmann, TB ;

Wolfe, BM ;

Locatelli, F ;

Goldhaber, SZ ;

Lewis, EJ .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549

[2] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].

Lewis, EJ ;

Hunsicker, LG ;

Clarke, WR ;

Berl, T ;

Pohl, MA ;

Lewis, JB ;

Ritz, E ;

Atkins, RC ;

Rohde, R ;

Raz, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860

[3] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].

LEWIS, EJ ;

HUNSICKER, LG ;

BAIN, RP ;

ROHDE, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462

[4] Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease -: The task force on ACE-inhibitors of the European Society of Cardiolgy [J].

López-Sendón, J ;

Swedberg, K ;

McMurray, J ;

Tamargo, J ;

Maggioni, AP ;

Dargie, H ;

Tendere, M ;

Waagstein, F ;

Kjekshus, J ;

Lechat, P ;

Torp-Pedersen, C .

EUROPEAN HEART JOURNAL, 2004, 25 (16) :1454-1470

[5] Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review [J].

Strippoli, GFM ;

Craig, M ;

Deeks, JJ ;

Schena, FP ;

Craig, JC .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7470) :828-831

[6] Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE [J].

Verma, S ;

Leiter, LA ;

Lonn, EM ;

Straus, MH .

EUROPEAN HEART JOURNAL, 2005, 26 (14) :1347-1349

[7] Angiotensin receptor blockers and myocardial infarction - These drugs may increase myocardial infarction - and patients may need to be told [J].

Verma, S ;

Strauss, M .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7477) :1248-1249

← 1 →